Business
In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) and prescribed in the United States within 48 hours following its approval.
Since 2018, Shuijiang Town, a remote mountainous area in Yichun City, east China's Jiangxi Province, has witnessed the rapid growth of its wig industry from scratch. Last year, 34 new wig enterprises were established in the town, bringing the total number to 93, in addition to more than 30 wig workshops.
The Chinese economy has maintained good recovery momentum, beginning the year on a solid note as the country's macro policies took effect, official data showed Monday.
Since 2018, Shuijiang Town, a remote mountainous area in Yichun City, east China's Jiangxi Province, has witnessed the rapid growth of its wig industry from scratch. Last year, 34 new wig enterprises were established in the town, bringing the total number to 93, in addition to more than 30 wig workshops.
In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) and prescribed in the United States within 48 hours following its approval.
The Chinese economy has maintained good recovery momentum, beginning the year on a solid note as the country's macro policies took effect, official data showed Monday.
Industries
BACK TO TOP
  • Sports
  • Soccer
  • Basketball
  • Tennis
  • Formula One
  • Athletics
  • Others
  • Entertainment
  • Celebrity
  • Movie & TV
  • Music
  • Theater & Arts
  • Fashion
  • Beauty Pageant
Edition:
Link:    
About CE.cn | About the Economic Daily | Contact us
Copyright 2003-2024 China Economic Net. All right reserved
more